Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

Understanding hormones is key to treating certain skin conditions.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Sex and stress steroids quickly change brain cell structures in the hippocampus.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

The mouse model could be useful for baldness research and testing treatments like testosterone, cyproterone acetate, and minoxidil.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Androgen receptors help prostate cancer cells grow and resist drugs.

The exact cause of male pattern baldness is unclear, but it may involve factors beyond androgens, offering new treatment possibilities.

Androgens can both increase and decrease hair growth in different parts of the body.